Ulipristal D3

Detection by HPLC and structural characterization by NMR and MS of a natural deuterium isotopologue of ulipristal acetate
Zoltán Béni, Judit Orgoványi, János Kóti, Csaba Sánta, János Horváth, Sándor Mahó, Csaba SzántayJr.
Journal of Pharmaceutical and Biomedical Analysis Volume 98, September 2014, Pages 279-286
 
Optimization and Validation of HPTLC Method for Estimation of Ulipristal Acetate in Presence of Its Forced Degradation Products
Gulzar Kamdar, Sonal Desai
Journal of Chromatographic Science, Volume 58, Issue 5, May/June 2020, Pages 427–432
 
Extractive Spectrophotometric Determination of Ulipristal Acetate using Naphthol Blue Black
Giri Prasad Gorumutchu , Venkata Nadh Ratnakaram
Research J. Pharm. and Tech. 12(3): March 2019

Ulipristal D3 is chemically (8S,11R,13S,14S,17R)-17-acetyl-17-hydroxy-13-methyl-11-(4-(methyl(methyl-d3)amino)phenyl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one. Ulipristal D3 is supplied with detailed characterization data compliant with regulatory guideline. Ulipristal D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ulipristal.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.